Bicara Therapeutics Inc. Common Stock

BCAXNASDAQHealthcare● Active

$20.10

+$0.10(+0.50%)

Market Cap$1.1B

P/E Ratio—

52W High$24.25

52W Low$8.48

Avg Volume557K

Open$20.55

Beta-0.53

Employees Ownership Insider Trades

Bicara Therapeutics Inc. Common Stock (BCAX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BCAX · as of Mar 30, 2026

Latest filing snapshot

200,000

+0+0.00%vs prior year

Bicara Therapeutics Inc. Common Stock (BCAX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

200,000

Change (1Y)

Growth % (1Y)

+0.00%

Revenue / Employee

—

Net Income / Employee

$-690

Market Cap

$1.1B

BCAX Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)	SEC filing link
2026-03-30	2025-12-31	200,000	+0	+0.00%
2025-03-27	2024-12-31	200,000	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BCAX

Bicara Therapeutics Inc. Common StockYOU

200,000$1.1B #2

FTRE

Fortrea Holdings Inc.

15,000$1.6B #3

MRVI

Maravai LifeSciences Holdings, Inc.

570$1.4B #4

PHAT

Phathom Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

165$964M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BCAX peer comparison

About BCAX employees

BCAX Employees · Headcount

Bicara Therapeutics Inc. Common Stock (BCAX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Bicara Therapeutics Inc. Common Stock had 200,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Bicara Therapeutics Inc. Common Stock's workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BCAX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Bicara Therapeutics Inc. Common Stock had 200,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Bicara Therapeutics Inc. Common Stock employee counthow many employees does Bicara Therapeutics Inc. Common Stock haveBCAX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30